Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis (2012)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Assunto: ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKANO, Diogo Eiji e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 03 out. 2024. , 2012APA
Takano, D. E., Ribeiro, A. G., & Kano, E. K. (2012). Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Takano DE, Ribeiro AG, Kano EK. Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF050.[citado 2024 out. 03 ]Vancouver
Takano DE, Ribeiro AG, Kano EK. Rituximab and hematological adverse drug reaction in patients with rheumatoid arthritis. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF050.[citado 2024 out. 03 ]